Boston, MACIK 12160934 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
22 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Vicor Corp | 226.3K | $24.80M | 13.6% | −27.9K | Reduced |
| 2 | Newmont Corp | 208.2K | $20.79M | 11.4% | −14.4K | Reduced |
| 3 | Chevron Corp New | 97.2K | $14.81M | 8.1% | −7.5K | Reduced |
| 4 | Vistra Corp |
| 74.9K |
| $12.08M |
| 6.6% |
| −9.7K |
| Reduced |
| 5 | Alphabet Inc | 35.5K | $11.12M | 6.1% | −10.6K | Reduced |
| 6 | Antero Resources Corp | 290.3K | $10.00M | 5.5% | +35.8K | Added |
| 7 | Cvs Health Corp | 122.5K | $9.72M | 5.3% | −8.7K | Reduced |
| 8 | The Cigna Group | 34.2K | $9.41M | 5.2% | +11.7K | Added |
| 9 | Nutrien Ltd | 143.8K | $8.96M | 4.9% | +15.7K | Added |
| 10 | Bristol-Myers Squibb Co | 151.7K | $8.18M | 4.5% | −26.3K | Reduced |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio